Delivery Order SPE2DB22D3301-SPE2DB25FX4GK

Award Date 10/23/24
Potential Completion Date 11/14/24
Potential Value $7.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is a delivery order under the company's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The IDC, valued at $999,999,999 and running through November 2026, enables the efficient procurement of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,242.15 firm fixed-price delivery order is for the supply of 4566212961 - BRUKINSA 80 MG CAPSULE 120S, with a period of performance through November 18, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,740.00 Firm Fixed Price Delivery Order covers the supply of BRUKINSA 80 MG CAPSULE 120S, a pharmaceutical product, to support military healthcare programs. The award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is a delivery order valued at $57,937.20 for the supply of BRUKINSA 80 MG CAPSULE 120S. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a civilian agency that supports military healthcare programs. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,492.44 delivery order contract is for the supply of BRUKINSA 80 MG CAPSULES 120S, a specialty medication. The contract has a firm fixed price pricing type and a completion date of January 2, 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the provision of the pharmaceutical product BRUKINSA 80 MG CAPSULE 120S. The $7,242.15 firm fixed price delivery order was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a unit of the Department of Defense (DoD). Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 with DLA Troop Support Medical to deliver a comprehensive range of...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of BRUKINSA 80 MG CAPSULE 120S. The firm-fixed-price delivery order, valued at $7,242.15, has an ultimate completion date of December 3, 2024. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,242.15 firm fixed-price delivery order is for the supply of BRUKINSA 80 MG CAPSULE 120S, a prescription drug product. The contract has an ultimate completion date of November 29, 2024 and is not designated with any set-aside requirements, indicating open competition. AmerisourceBergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,242.15, is for the delivery of the drug BRUKINSA 80 MG CAPSULE 120S. This is a firm fixed-price delivery order contract with a completion date of December 5, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,242.15 delivery order contract is for the supply of BRUKINSA 80 MG CAPSULE 120S, a specialty medication. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, which serves as a primary vehicle for providing a comprehensive range...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB25FX4GK
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $7,242.15 firm fixed-price delivery order is for the supply of BRUKINSA 80 MG CAPSULE 120S, a prescription medication. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999, which serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has no set-aside designation, indicating open competition. In addition to the DLA IDC, Amerisourcebergen also holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000, for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 1/22/25, 9:12 AM